糖尿病前期口服葡萄糖耐量试验中胰高血糖素抑制不足:系统评价与荟萃分析
该系统评价与荟萃分析检索多个数据库,评估糖尿病前期(preDM)与正常糖耐量(NGT)人群在75 g口服葡萄糖耐量试验(OGTT)中胰高血糖素的空腹水平及对葡萄糖抑制的反应。结果显示preDM在0、0.5、1、1.5小时胰高血糖素水平显著高于NGT,尽管其各时间点血糖更高且0、1、1.5、2小时胰岛素更高。亚组分析提示放射免疫法与ELISA法结果不一致,糖耐量受损(IGT)组0.5小时胰高血糖素未被抑制且高于NGT。
要点
- preDM在OGTT 0、0.5、1、1.5小时胰高血糖素水平显著高于NGT,尽管血糖和部分时间点胰岛素更高。
- 亚组分析中放射免疫法研究显示preDM 0.5、1小时胰高血糖素高于NGT,ELISA法研究则与NGT相似。
- IGT组0.5小时胰高血糖素未被抑制且高于NGT,IFG组对葡萄糖抑制的反应性保留。
核心结论
- 糖尿病前期在OGTT期间胰高血糖素未被充分抑制,胰高血糖素调节异常是IFG和IGT的共同机制之一。
研究设计与样本
- 系统评价与荟萃分析,检索Pubmed、Embase、Web of Science和Cochrane Library,纳入评估preDM与NGT队列在75 g OGTT期间胰高血糖素水平的研究。
- 采用随机效应模型合并胰高血糖素、葡萄糖和胰岛素数据。
主要发现
- preDM与NGT两组在葡萄糖负荷后胰高血糖素水平均下降,但preDM在0、0.5、1、1.5小时胰高血糖素水平显著高于NGT。
- preDM在OGTT各时间点血糖均高于NGT,且在0、1、1.5、2小时胰岛素水平更高。
- 放射免疫法亚组中preDM在0.5小时和1小时胰高血糖素高于NGT,ELISA法亚组中preDM胰高血糖素与NGT相似但血糖更高。
- IGT组0.5小时胰高血糖素未被抑制且高于NGT,IFG组对葡萄糖抑制的反应性保留。
关键数值与推荐
- OGTT采用75 g口服葡萄糖耐量试验。
- preDM在0、0.5、1、1.5小时胰高血糖素水平显著高于NGT。
- 放射免疫法亚组preDM在0.5小时和1小时胰高血糖素高于NGT。
- ELISA法亚组preDM胰高血糖素与NGT相似。
- IGT组0.5小时胰高血糖素未被抑制且高于NGT。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Glucagon plays a role in the development of type 2 diabetes, yet its role in prediabetes (preDM) remains uncertain. OBJECTIVE: To evaluate glucagon levels in the fasting state and its response to glucose inhibition in preDM through meta-analysis. METHODS: A systematic search across Pubmed, Embase, Web of Science, and Cochrane Library identified studies assessing glucagon levels during 75 g oral glucose tolerance test (OGTT) in both preDM and normal glucose tolerance (NGT) cohorts. Data on glucagon, glucose, and insulin were pooled using a random-effect model. RESULTS: Although glucagon levels decreased in both preDM and NGT groups upon glucose challenge, glucagon levels at 0 hours, 0.5 hours, 1 hour, and 1.5 hours in preDM were significantly higher compared to NGT, despite higher glucose levels at all time points and higher insulin levels at 0 hours, 1 hour, 1.5 hours, and 2 hours during OGTT. Subgroup analysis revealed that in studies using the radioimmunoassay method, glucagon levels in preDM were higher at 0.5 hours and 1 hour than NGT, while in studies using the ELISA method, glucagon levels were similar to those of the NGT group despite higher glucose in preDM compared to NGT. Fasting glucagon level was inadequately suppressed in both impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). Responsiveness to glucose inhibition was preserved in IFG, while glucagon level in IGT group at 0.5 hours after glucose intake was not suppressed and was higher than NGT. CONCLUSION: Glucagon was not adequately suppressed during OGTT in preDM. Glucagon dysregulation is a contributing mechanism underlying both IFG and IGT.
引用
- Chang L, Liu Y, Gu Y, et al. Inadequate Glucagon Suppression During OGTT in Prediabetes: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2024. PMID: 38963886. doi:10.1210/clinem/dgae460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。